agilon health, inc.
NYSE:AGL
3.48 (USD) • At close February 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,450.932 | 1,482.758 | 1,604.354 | 1,056.073 | 1,215.66 | 1,149.052 | 1,136.147 | 689.774 | 694.858 | 670.134 | 653.445 | 462.886 | 458.613 | 498.956 | 413.104 | 321.007 | 312.684 | 293.594 | 291.048 | 198.126 |
| Cost of Revenue
| 1,515.099 | 1,456.49 | 1,535.11 | 1,155.676 | 1,185.183 | 1,091.859 | 1,058.851 | 1,916.147 | 668.946 | 636.22 | 610.981 | 461.999 | 443.656 | 476.177 | 384.015 | 315.722 | 287.258 | 255.124 | 266.079 | 196.867 |
| Gross Profit
| -64.167 | 26.268 | 69.244 | -99.603 | 30.477 | 57.193 | 77.296 | -1,226.373 | 25.912 | 33.914 | 42.464 | 0.887 | 14.957 | 22.779 | 29.089 | 5.285 | 25.426 | 38.47 | 24.969 | 1.259 |
| Gross Profit Ratio
| -0.044 | 0.018 | 0.043 | -0.094 | 0.025 | 0.05 | 0.068 | -1.778 | 0.037 | 0.051 | 0.065 | 0.002 | 0.033 | 0.046 | 0.07 | 0.016 | 0.081 | 0.131 | 0.086 | 0.006 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 63.123 | 69.612 | 76.422 | 63.277 | 74.138 | 81.499 | 66.658 | 75.207 | 51.98 | 51.924 | 39.834 | 53.84 | 46.643 | 317.561 | 37.777 | 41.358 | 31.926 | 36.403 | 27.605 | 30.636 |
| Selling & Marketing Expenses
| 0 | -0.868 | -2.415 | 1.419 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 63.123 | 68.744 | 74.007 | 64.696 | 74.138 | 81.499 | 66.658 | 75.207 | 51.98 | 51.924 | 39.834 | 53.84 | 46.643 | 317.561 | 37.777 | 41.358 | 31.926 | 36.403 | 27.605 | 30.636 |
| Other Expenses
| 6.218 | 4.841 | 5.892 | 6.839 | 5.69 | 15.687 | 4.189 | -9.865 | 4.888 | 3.042 | 3.373 | -8.534 | -0.269 | 2.967 | 3.427 | 2.886 | -0.469 | -0.074 | 0.122 | 0 |
| Operating Expenses
| 69.341 | 68.744 | 74.007 | 64.696 | 79.448 | 87.014 | 70.847 | 75.207 | 55.43 | 54.966 | 43.207 | 53.84 | 50.558 | 321.142 | 41.204 | 45.028 | 35.27 | 39.722 | 30.803 | 34.351 |
| Operating Income
| -133.508 | -42.476 | -4.763 | -164.299 | -48.971 | -29.821 | 15.921 | -63.283 | -29.518 | -21.052 | 1.526 | -57.756 | -35.601 | -298.363 | -12.115 | -39.743 | -9.844 | -1.252 | -5.834 | -32.613 |
| Operating Income Ratio
| -0.092 | -0.029 | -0.003 | -0.156 | -0.04 | -0.026 | 0.014 | -0.092 | -0.042 | -0.031 | 0.002 | -0.125 | -0.078 | -0.598 | -0.029 | -0.124 | -0.031 | -0.004 | -0.02 | -0.165 |
| Total Other Income Expenses Net
| 16.486 | 13.099 | 10.292 | -2.573 | 18.698 | 14.099 | 7.939 | 7.341 | -0.426 | 0.594 | 1.398 | -9.374 | -1.136 | 1.469 | -1.605 | 0.933 | -2.422 | -2.154 | -2.027 | -2.7 |
| Income Before Tax
| -117.022 | -30.245 | 3.114 | -166.872 | -30.273 | -15.722 | 14.2 | -55.942 | -29.944 | -20.458 | 0.655 | -57.247 | -36.737 | -296.894 | -13.72 | -38.81 | -12.266 | -3.406 | -7.861 | -35.313 |
| Income Before Tax Ratio
| -0.081 | -0.02 | 0.002 | -0.158 | -0.025 | -0.014 | 0.012 | -0.081 | -0.043 | -0.031 | 0.001 | -0.124 | -0.08 | -0.595 | -0.033 | -0.121 | -0.039 | -0.012 | -0.027 | -0.178 |
| Income Tax Expense
| -0.59 | 0.417 | -0.133 | 0.267 | 1.21 | 1.073 | -1.759 | 0.107 | 0.559 | 0.58 | -0.071 | -0.179 | 0.256 | 0.435 | 0.016 | 0.791 | 0.035 | 0.039 | 10.509 | 0.259 |
| Net Income
| -117.615 | -30.682 | 2.699 | -182.885 | -31.436 | -16.749 | 16.022 | -56.049 | -30.668 | -21.038 | 0.726 | -57.068 | -35.843 | -298.845 | -15.078 | -24.215 | -11.827 | -7.911 | -16.099 | -34.902 |
| Net Income Ratio
| -0.081 | -0.021 | 0.002 | -0.173 | -0.026 | -0.015 | 0.014 | -0.081 | -0.044 | -0.031 | 0.001 | -0.123 | -0.078 | -0.599 | -0.036 | -0.075 | -0.038 | -0.027 | -0.055 | -0.176 |
| EPS
| -0.29 | -0.075 | 0.007 | -0.45 | -0.078 | -0.041 | 0.039 | -0.14 | -0.075 | -0.052 | 0.002 | -0.15 | -0.092 | -0.79 | -0.046 | -0.063 | -0.031 | -0.021 | -0.042 | -0.12 |
| EPS Diluted
| -0.29 | -0.075 | 0.007 | -0.45 | -0.078 | -0.041 | 0.038 | -0.14 | -0.075 | -0.052 | 0.002 | -0.15 | -0.092 | -0.79 | -0.046 | -0.063 | -0.031 | -0.021 | -0.042 | -18.01 |
| EBITDA
| -112.429 | -22.641 | 1.081 | -160.144 | -23.312 | -8.619 | 4.794 | -50.326 | -25.494 | -16.471 | 4.899 | -52.769 | -31.933 | -291.782 | -7.298 | -33.104 | -6.812 | 2.156 | -2.349 | -58.438 |
| EBITDA Ratio
| -0.077 | -0.025 | 0.001 | -0.151 | -0.019 | -0.008 | 0.018 | -0.09 | -0.037 | -0.016 | 0.007 | -0.124 | -0.07 | -0.585 | -0.021 | -0.103 | -0.022 | 0.007 | -0.008 | -0.295 |